Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?
Novo Nordisk is leaning into convenience as it tries to regain its lead in the GLP-1 weight-loss space.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.